Lung transplant device LungFX won FDA approval Monday for centralized ex vivo lung perfusion, a technology that reconditions ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results